Federal
-
Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
Watson Pharmaceuticals has received a request for additional information from the Federal Trade Commission (FTC) in connection with the company’s pending acquisition of privately held Arrow Group. The information request was issued under notifi…
Federal | 13 August 2009
